PAX2 plays a key role in kidney development, as it activates downstream targets that ultimately lead to podocyte formation and it has been hypothesized that dysregulation of PAX2 targets, such as WT1, can disrupt the development and/or function of the podocyte which in turn leads to FSGS (26). Here, WT1 is linked to focal segmental glomerulosclerosis.